Researcher journeys

Impact Stories

Read more in the stories below about how UniQuest is partnering with UQ researchers to deliver solutions for a better world.

Contact Us

UniQuest commercialises UQ research to create change. Speak to us about commercialising your research ideas today.

Contact us

Researchers FAQ

General Questions

Uciministi sequatur sanis dolori con excepta cumquis qui rem libusda si ut ut ex eniendi psundisqui berio cor aliquias eum ium inctem aut as escium ium expligenimin praturiberum fugiam hictore iciunti cusciment molor sim simagni antintium endandi tionsequibus con con reptati officimus sunt eaqui dolorio nsequis minciantur? Mincidel exceria aut volorro tem re, occulpa quas dentota delibus rehenem ut odis expla si aute experatur

Uciministi sequatur sanis dolori con excepta cumquis qui rem libusda si ut ut ex eniendi psundisqui berio cor aliquias eum ium inctem aut as escium ium expligenimin praturiberum fugiam hictore iciunti cusciment molor sim simagni antintium endandi tionsequibus con con reptati officimus sunt eaqui dolorio nsequis minciantur? Mincidel exceria aut volorro tem re, occulpa quas dentota delibus rehenem ut odis expla si aute experatur?

Uciministi sequatur sanis dolori con excepta cumquis qui rem libusda si ut ut ex eniendi psundisqui berio cor aliquias eum ium inctem aut as escium ium expligenimin praturiberum fugiam hictore iciunti cusciment molor sim simagni antintium endandi tionsequibus con con reptati officimus sunt eaqui dolorio nsequis minciantur? Mincidel exceria aut volorro tem re, occulpa quas dentota delibus rehenem ut odis expla si aute experatur?

Uciministi sequatur sanis dolori con excepta cumquis qui rem libusda si ut ut ex eniendi psundisqui berio cor aliquias eum ium inctem aut as escium ium expligenimin praturiberum fugiam hictore iciunti cusciment molor sim simagni antintium endandi tionsequibus con con reptati officimus sunt eaqui dolorio nsequis minciantur? Mincidel exceria aut volorro tem re, occulpa quas dentota delibus rehenem ut odis expla si aute experatur?


Agreements

Uciministi sequatur sanis dolori con excepta cumquis qui rem libusda si ut ut ex eniendi psundisqui berio cor aliquias eum ium inctem aut as escium ium expligenimin praturiberum fugiam hictore iciunti cusciment molor sim simagni antintium endandi tionsequibus con con reptati officimus sunt eaqui dolorio nsequis minciantur? Mincidel exceria aut volorro tem re, occulpa quas dentota delibus rehenem ut odis expla si aute experatur?

Uciministi sequatur sanis dolori con excepta cumquis qui rem libusda si ut ut ex eniendi psundisqui berio cor aliquias eum ium inctem aut as escium ium expligenimin praturiberum fugiam hictore iciunti cusciment molor sim simagni antintium endandi tionsequibus con con reptati officimus sunt eaqui dolorio nsequis minciantur? Mincidel exceria aut volorro tem re, occulpa quas dentota delibus rehenem ut odis expla si aute experatur?

Uciministi sequatur sanis dolori con excepta cumquis qui rem libusda si ut ut ex eniendi psundisqui berio cor aliquias eum ium inctem aut as escium ium expligenimin praturiberum fugiam hictore iciunti cusciment molor sim simagni antintium endandi tionsequibus con con reptati officimus sunt eaqui dolorio nsequis minciantur? Mincidel exceria aut volorro tem re, occulpa quas dentota delibus rehenem ut odis expla si aute experatur?

Uciministi sequatur sanis dolori con excepta cumquis qui rem libusda si ut ut ex eniendi psundisqui berio cor aliquias eum ium inctem aut as escium ium expligenimin praturiberum fugiam hictore iciunti cusciment molor sim simagni antintium endandi tionsequibus con con reptati officimus sunt eaqui dolorio nsequis minciantur? Mincidel exceria aut volorro tem re, occulpa quas dentota delibus rehenem ut odis expla si aute experatur?


Commercialisation

Our offering to UQ

If you are employed at The University of Queensland, we can work with you to
identify, protect and commercialise your intellectual property.

Startups and spin-outs

Access to industry

Licensing

Drug discovery and development - QEDDI

IP-protection-icon

IP protection
and management

Business
development

Contact our team

We have market-facing staff with industry experience, embedded in UQ’s faculties and institutes

Staff of UQ’s Faculty of Business, Economics and Law can contact our Social and Behavioural Sciences Team, led by Anne Bannister.

Contact Anne

Staff of the Faculty of Engineering, Architecture and Information Technology can contact our Physical Sciences Team, led by Colin Davies.

Contact Colin

Staff from UQ’s Faculty of Health and Behavioural Sciences can contact UniQuest’s Life Sciences Team, led by Craig Belcher.

Contact Craig

Staff from the School of Nursing, Midwifery and Social Work and the School of Psychology can contact our Social and Behavioural Sciences Team, led by Anne Bannister.

Contact Anne

Staff of UQ’s Faculty of Humanities and Social Sciences can contact our Social and Behavioural Sciences Team, led by Anne Bannister.

Contact Anne

Staff from UQ’s Faculty of Medicine are invited to contact our Life Sciences Team, led by Craig Belcher.

Contact Craig

Staff from UQ’s Faculty of Science can contact either our Life Sciences Team led by Craig Belcher, or our Physical Sciences Team, led by Colin Davies.

Contact CraigContact Colin

Staff from the Australian Institute for Bioengineering and Nanotechnology can contact our Life Sciences Team, led by Craig Belcher.

Contact Craig

UQ staff at the Frazer Institute can contact our Life Sciences Team, led by Craig Belcher.

Contact Craig

Staff of the Global Change Institute can contact our Physical Sciences Team, led by Colin Davies.

Contact Colin

Staff from the Institute for Molecular Bioscience can contact our Life Sciences Team, led by Craig Belcher.

Contact Craig

Staff from the Institute for Social Science Research can contact our Social and Behavioural Sciences Team, led by Anne Bannister.

Contact Anne

Staff from the Mater Research Institute – UQ (MRI-UQ) can contact our Life Sciences Team, led by Craig Belcher.

Contact Craig

UQ staff at the Queensland Alliance for Agriculture and Food Innovation (QAAFI) can contact our Life Sciences Team, led by Craig Belcher.

Contact Craig

Staff from the Queensland Brain Institute can contact our Life Sciences Team, led by Craig Belcher.

Contact Craig

Staff from the Sustainable Minerals Institute can contact our Physical Sciences Team, led by Colin Davies.

Contact Colin

Workshops and Events

Find out more about UniQuest’s Research Commercialisation Workshops and industry events.

Find out more

Researchers

Australia’s leading research commercialisation company

UniQuest is the commercialisation company of The University of Queensland (UQ).

In partnership with UQ researchers, we create impact through the commercialisation of UQ intellectual property (IP).  Established in 1984, UniQuest’s commercialisation track record positions UQ as the leader of research commercialisation in Australasia.

Startups and spin-outs

Access to capital

Licensing

Drug discovery and development - QEDDI

IP-protection-icon

IP protection
and management

Commercial
negotiation

News

The University of Queensland’s small molecule drug discovery facility will open its doors to researchers from across Australia for the first time thanks to a National Collaborative Research Infrastructure Strategy (NCRIS) funding injection.

The Queensland Emory Drug Discovery Initiative (QEDDI) will partner with research groups from across Australia who can benefit from its drug discovery services after receiving $1.9m from Therapeutic Innovation Australia (TIA) through the NCRIS.

QEDDI, which is managed by UQ’s commercialisation company UniQuest, has previously only made its services available to researchers at UQ.

Find out more
Events

Industry Connect

Industry Connect events enable pre-qualified collaborations between researchers and industry.

Find out more
Workshop

Research Commercialisation Workshops

Are you an early-career researcher? Want to make an impact?

We hold free, two-day workshops focussing on intellectual property and commercialisation.

Find out more

Impact Stories

From idea to impact, UniQuest commercialises UQ research to create change.

gardasil cervica cancer vaccine

Gardasil®: A global solution to eradicating cervical cancer

From its origins in groundbreaking research at The University of Queensland, to its use in more than 130 countries worldwide, the Gardasil® cervical cancer vaccine has led to an approximate 90 per cent decrease in the prevalence of human papillomavirus (HPV), the major cause of cervical cancer.

Encapsulated probiotic drink a world first

The world’s first encapsulated probiotic drink uses patented micro-shield technology to deliver targeted in-gut release of effective probiotics.

Bringing the benefits of positive parenting and healthy communities to the world

The Triple P-Positive Parenting Program is changing the lives of millions of families around the world and helping to build stronger, more resilient communities.

Available technologies

Our specialised team delivers the highest quality commercialisation expertise and can help you access the world class research, resources and intellectual property of UQ. We have a suite of available technologies and discoveries that could give your business an innovative edge.

Discover more

The UniQuest Extension Fund

The UniQuest Extension Fund is a $32 million investment fund designed to support the start-up ecosystem at The University of Queensland (UQ).

The Fund will provide capital as well as skills and connections to help UQ start-up companies grow their teams, develop commercial-grade products and services, and drive customer acquisition and global expansion.

Investments will be made across three phases of the funding lifecycle of start-up companies:

hand leaf icon

Pre-seed

$2 million reserve

Initial investment in a project opportunity that has commercial potential prior to start-up company formation

leaves icon

Seed

$10 million reserve

Foundation investment in a start-up company

macro icon

Follow-on

$20 million reserve

Subsequent investments in a start-up company

Sources of commercial opportunity

Student start-ups

Research IP start-ups

Alumni start-ups

The Extension Fund will seek to invest in three distinct sources of commercial opportunity at UQ: companies initiated by UQ students through and outside of the UQ Ventures ilab program; through alumni-generated start-ups and those derived as outcomes of UQ research.

Where appropriate, the Extension Fund may co-invest alongside other parties.  These co-investors may be third party entities and may be related to or associated with UniQuest.

The Extension Fund has a broad investment mandate, which is not limited to any particular sector, industry or business model.

The ideal investment opportunity

The following characteristics would constitute the 'ideal investment opportunity', although we acknowledge that such may not be available in the UQ marketplace - especially with student and early stage projects and start-up opportunities

A new technology

or a novel application of technology with potential to drive disruption within a defined market sector

Strong early market validation

where possible evidenced by the business having already generated its first commercial revenue

Founders with exceptional credentials

in terms of specific industry expertise or prior experience in early-stage, high-growth companies

A business model

that delivers (or is likely to deliver) attractive and sustainable unit economics

A target market

that is very large, growing and well-defined

Potential for sustained revenue growth

over the long term

A credible path

for the Extension Fund to exit its investment within a horizon commensurate with the opportunity

Further information

Download a brochure for more information. We have information tailored for potential investors and investees.

For investors
Download (PDF)
For investees
Download (PDF)

Contact us

Please contact us if you would like further details.
In any initial communication, please only provide non-confidential information.

Contact us

Impact

$1b+

Raised to take university technology to market

150+

Active licence agreements

$70b+

Gross product sales of licensed
UQ technologies

$961m+

In revenue returned to UQ since 2002

125+

Companies created from UQ’s intellectual property portfolio

360+

Granted US patents

Researcher Journeys

Read about how UQ researchers have partnered with UniQuest to deliver solutions for a better world.

gardasil cervica cancer vaccine

Gardasil®: A global solution to eradicating cervical cancer

From its origins in groundbreaking research at The University of Queensland, to its use in more than 130 countries worldwide, the Gardasil® cervical cancer vaccine has led to a decrease of approximately 90 per cent in the prevalence of human papillomavirus (HPV), the major cause of cervical cancer.

Encapsulated probiotic drink a world first

The world’s first encapsulated probiotic drink uses patented micro-shield technology to deliver targeted in-gut release of effective probiotics.

Bringing the benefits of positive parenting and healthy communities to the world

The Triple P-Positive Parenting Program is changing the lives of millions of families around the world and helping to build stronger, more resilient communities.

Two-thirds of MRI scanners around the world use UQ's MRI image technology

MRI scan technology is saving lives around the world

UQ’s innovative technology, which is used in most of the world’s MRI machines, has helped more than 8 billion people across the globe.

UQ's Vaxxas Nanopatch is a novel vaccine delivery technology to target vaccines to the cells immediately below the surface of the skin.

UQ technology with the power to revolutionise global vaccine delivery

Nanopatch™ technology developed by Professor Mark Kendall could have a global impact by improving vaccines so they no longer have to be administered by needle and syringe.

UQ's ResAppDx smartphone app is being used to diagnose respiratory diseases in a range of settings.

A smartphone app helping doctors and patients breathe easier

Just one cough and a simple and inexpensive new smartphone technology can instantly and accurately identify respiratory diseases.

UQ Research Impact

UQ research creates value that translates into impact for our local community, Australian society and in far-reaching places around the globe. UniQuest partners with UQ researchers to commercialise their research ideas.

UQ Research News

Contact our team

UniQuest commercialises UQ research to create change. Speak to us about commercialising your research ideas today.

Contact us